Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- befree-2016 importedOn "2016-02-19" NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_assertion wasGeneratedBy ECO_0000203 NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_assertion wasDerivedFrom befree-2016 NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_assertion SIO_000772 22351695 NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_assertion evidence source_evidence_literature NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.
- NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_assertion description "[ON 01910.Na (Rigosertib), a multikinase phosphoinositide 3-kinase (PI3K) inhibitor, is entering phase III trials for myelodysplastic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962278.RAD86tXrn6esROB4rCgrL6y0GZ4yZOklWVn2Abx4HqFrA130_provenance.